vs
Side-by-side financial comparison of NexPoint Real Estate Finance, Inc. (NREF) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $11.1M, roughly 1.7× NexPoint Real Estate Finance, Inc.). NexPoint Real Estate Finance, Inc. runs the higher net margin — 216.6% vs -3.0%, a 219.6% gap on every dollar of revenue. On growth, ROCKWELL MEDICAL, INC. posted the faster year-over-year revenue change (-25.6% vs -48.8%).
NexPoint Real Estate Finance, Inc. is a US-based commercial real estate finance firm that offers structured financing solutions for multifamily, office, industrial, and hospitality properties. It focuses on originating, managing and servicing a diversified portfolio of mortgage loans and real estate-related investments to deliver stable risk-adjusted returns to stakeholders.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
NREF vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.1M | $18.3M |
| Net Profit | $24.0M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | — | -2.2% |
| Net Margin | 216.6% | -3.0% |
| Revenue YoY | -48.8% | -25.6% |
| Net Profit YoY | 58.7% | 26.7% |
| EPS (diluted) | $0.47 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.1M | $18.3M | ||
| Q3 25 | $12.5M | $15.9M | ||
| Q2 25 | $12.1M | $16.1M | ||
| Q1 25 | $11.5M | $18.9M | ||
| Q4 24 | $21.7M | $24.7M | ||
| Q3 24 | $12.5M | $28.3M | ||
| Q2 24 | $6.7M | $25.8M | ||
| Q1 24 | $-12.8M | $22.7M |
| Q4 25 | $24.0M | $-554.0K | ||
| Q3 25 | $50.9M | $-1.8M | ||
| Q2 25 | $22.3M | $-1.5M | ||
| Q1 25 | $26.0M | $-1.5M | ||
| Q4 24 | $15.2M | $-756.0K | ||
| Q3 24 | $23.3M | $1.7M | ||
| Q2 24 | $12.1M | $343.0K | ||
| Q1 24 | $-14.6M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | — | -2.2% | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | — | -8.4% | ||
| Q1 25 | — | -7.2% | ||
| Q4 24 | — | -2.1% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | -5.8% |
| Q4 25 | 216.6% | -3.0% | ||
| Q3 25 | 407.0% | -11.0% | ||
| Q2 25 | 184.5% | -9.3% | ||
| Q1 25 | 225.6% | -8.0% | ||
| Q4 24 | 69.9% | -3.1% | ||
| Q3 24 | 186.4% | 5.9% | ||
| Q2 24 | 179.7% | 1.3% | ||
| Q1 24 | 114.3% | -7.6% |
| Q4 25 | $0.47 | $-0.01 | ||
| Q3 25 | $1.14 | $-0.05 | ||
| Q2 25 | $0.54 | $-0.05 | ||
| Q1 25 | $0.70 | $-0.04 | ||
| Q4 24 | $0.71 | $-0.02 | ||
| Q3 24 | $0.74 | $0.04 | ||
| Q2 24 | $0.40 | $0.01 | ||
| Q1 24 | $-0.83 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.1M | $10.7M |
| Total DebtLower is stronger | $771.2M | — |
| Stockholders' EquityBook value | $388.0M | $37.0M |
| Total Assets | $5.3B | $57.1M |
| Debt / EquityLower = less leverage | 1.99× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.1M | $10.7M | ||
| Q3 25 | $17.9M | $13.6M | ||
| Q2 25 | $9.1M | $12.5M | ||
| Q1 25 | $19.2M | $11.4M | ||
| Q4 24 | $3.9M | $15.7M | ||
| Q3 24 | $34.7M | $12.3M | ||
| Q2 24 | $4.3M | $11.9M | ||
| Q1 24 | $13.5M | $6.6M |
| Q4 25 | $771.2M | — | ||
| Q3 25 | $720.9M | — | ||
| Q2 25 | $815.6M | — | ||
| Q1 25 | $831.5M | — | ||
| Q4 24 | $799.3M | — | ||
| Q3 24 | $815.5M | — | ||
| Q2 24 | $861.0M | — | ||
| Q1 24 | $843.3M | — |
| Q4 25 | $388.0M | $37.0M | ||
| Q3 25 | $375.4M | $37.0M | ||
| Q2 25 | $348.2M | $30.4M | ||
| Q1 25 | $343.7M | $31.5M | ||
| Q4 24 | $336.5M | $32.6M | ||
| Q3 24 | $335.8M | $29.1M | ||
| Q2 24 | $327.5M | $23.5M | ||
| Q1 24 | $327.1M | $20.6M |
| Q4 25 | $5.3B | $57.1M | ||
| Q3 25 | $5.3B | $57.5M | ||
| Q2 25 | $5.4B | $52.6M | ||
| Q1 25 | $5.4B | $54.0M | ||
| Q4 24 | $5.4B | $59.2M | ||
| Q3 24 | $5.7B | $57.1M | ||
| Q2 24 | $6.6B | $53.0M | ||
| Q1 24 | $7.1B | $50.7M |
| Q4 25 | 1.99× | — | ||
| Q3 25 | 1.92× | — | ||
| Q2 25 | 2.34× | — | ||
| Q1 25 | 2.42× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 2.43× | — | ||
| Q2 24 | 2.63× | — | ||
| Q1 24 | 2.58× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.5M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | -0.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.5M | $2.3M | ||
| Q3 25 | $8.1M | $-1.3M | ||
| Q2 25 | $3.3M | $1.8M | ||
| Q1 25 | $16.0M | $-3.5M | ||
| Q4 24 | $4.4M | $865.0K | ||
| Q3 24 | $14.7M | $4.3M | ||
| Q2 24 | $-7.5M | $1.4M | ||
| Q1 24 | $17.7M | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | -0.19× | — | ||
| Q3 25 | 0.16× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.62× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.63× | 2.57× | ||
| Q2 24 | -0.62× | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NREF
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
